We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Intelligent Ultrasound Group Plc | LSE:MED | London | Ordinary Share | GB00BN791Q39 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.50 | 14.00 | 15.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIUG
RNS Number : 5654Z
Intelligent Ultrasound Group PLC
24 May 2021
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Company")
Notice of Annual General Meeting and 2020 Report and Accounts
Intelligent Ultrasound Group plc (AIM: IUG), the artificial intelligence software and simulation company, announces that the following documents have been published on the Company's website www.intelligentultrasound.com/reports-presentations/ .
- 2020 Report and Accounts; - Notice of 2021 Annual General Meeting (AGM Notice); and - Form of Proxy
Printed copies of the 2020 Report and Accounts and the 2021 AGM Notice have been posted to those shareholders that have requested hard copies.
The 2021 AGM will be held at the Company's registered office address at Floor 6A Hodge House, 114-116 St Mary Street, Cardiff, CF10 1DY at 11:00am on 22 June 2021.
The Company is closely monitoring public health guidance and legislation issued by the UK government in relation to the Covid pandemic. At the current time, the government continues to place restrictions on mass gatherings and social contact. However, it is expected shareholder attendance will be possible under the government's published roadmap and any shareholders intending to attend the AGM are asked to register their intention as soon as possible by emailing intelligentultrasound@walbrookpr.com. However, the Company is strongly encouraging all shareholders to exercise their votes by submitting their Form of Proxy electronically or by post in advance of the AGM in accordance with the AGM Notice.
The Board will keep these AGM arrangements under review and the Board will update shareholders via the Regulatory News Service (RNS) as appropriate, with any such announcements also uploaded to the Company's website.
Enquiries:
Intelligent Ultrasound Group www. intelligentultrasound.com plc Stuart Gall, CEO Tel: +44 (0)29 2075 6534 Helen Jones, CFO Cenkos Securities - Nominated Advisor Tel: +44 (0)20 7397 8900 and Broker Giles Balleny / Max Gould (Corporate Finance) Dale Bellis / Julian Morse (Sales) Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com Anna Dunphy / Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) develops artificial intelligence-based clinical image analysis software tools for the diagnostic medical ultrasound market and hi-fidelity virtual reality simulators for the ultrasound training market. Based in Cardiff in the UK and Atlanta in the US, the Group operates two divisions:
Clinical AI Division
Focusses on developing deep learning-based algorithms to make ultrasound machines smarter and more accessible. Products in the market include :
ScanNav Assist
ScanNav Assist uses machine-learning based algorithms to automatically identify and grade ultrasound images. GE Healthcare's SonoLyst software on their Voluson SWIFT ultrasound machine incorporates the ScanNav Assist AI technology and has received 510(k) clearance from the FDA for sale in the USA. SonoLyst is the world's first fully integrated AI tool that recognises the 20 views recommended by the International Society of Ultrasound in Obstetrics and Gynaecology mid-trimester practice guidelines for fetal imaging.
ScanNav Anatomy
ScanNav Anatomy PNB uses machine-learning based algorithms to simplify ultrasound-guided needling by providing the user with real-time AI-based anatomy highlighting software for a range of medical procedures. ScanNav Anatomy has received CE approval and has also been submitted for FDA regulatory approval.
ScanNav Anatomy PNB is therefore not available for sale in the US or any other territory requiring government approval for this type of product.
Simulation Division
Focusses on hi-fidelity ultrasound education and training through simulation. Its main products are the ScanTrainer OBGYN training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid module and the new AI-based Anatomy PNB training simulator. To date over 1,000 simulators have been sold to over 600 medical institutions around the world.
www.intelligentultrasound.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NOASEWSALEFSESI
(END) Dow Jones Newswires
May 24, 2021 04:09 ET (08:09 GMT)
1 Year Intelligent Ultrasound Chart |
1 Month Intelligent Ultrasound Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions